Clinical-development handoffs: a sponsor checklist for scope and decision ownership

By Margaret Emerson  |  BioBoston CRO

Why a handoff is a decision problem, not merely a document transfer

A clinical-development handoff can look complete while important work remains unowned. A clinical operations team may have shared the timeline, the vendor may have received the latest protocol, and the project manager may have closed the meeting minutes. Yet the downstream group may still lack a named person who can accept the deliverable, resolve an exception, or approve a change before the next milestone.

For an emerging sponsor using a primary contract research organization (CRO) and specialist vendors, the problem becomes more complicated. One organization prepares an output; another checks it; a third depends on it; and an authorized sponsor representative may need to make a decision that has not been delegated to a vendor. A useful handoff therefore records not just what was transferred but who is authorized to decide what happens next.

The checklist below is a practical project-control method. It should be tailored to each study's protocol, agreements, quality management system, stage of development, applicable regulations and critical-to-quality factors. It does not replace contractual transfer-of-activities documentation, clinical judgment, safety reporting, or sponsor oversight.

1. Define the handoff item precisely

Avoid descriptions such as 'data ready' or 'medical writing complete.' Write the item so that the recipient knows what to inspect. Identify the deliverable, its version, format, source system, owner, due date, intended use, and destination. For example: 'final reconciled laboratory transfer specification, version 2.1, for data-management acceptance before test transfer,' rather than 'lab files.'

For each item, separate three dates: the creator's planned completion date, the receiving team's acceptance date, and the downstream decision or milestone date. Those dates can differ, and a single green status can conceal a critical gap.

2. Name four different responsibilities

A simple handoff record benefits from four explicit roles:

·         Preparer / performer: Produces the item or performs the agreed activity.

·         Reviewer: Checks technical completeness and identifies discrepancies within their defined remit.

·         Approver / decision owner: Has the delegated authority to accept the item or approve a relevant change. Where sponsor approval is required, identify the sponsor role rather than assuming a CRO project manager may approve it.

·         Recipient / downstream owner: Takes possession of the accepted item and confirms that its dependencies are understood.

One person can hold several roles only when the study's procedures, contracts and required independence allow it. Use named individuals or defined role owners with a clear escalation substitute; a generic 'team' address rarely makes an adequate decision owner.

3. Agree on acceptance evidence before work begins

A handoff cannot be measured only by whether a file was uploaded. Define a small set of acceptance criteria proportional to the item's risk and intended use. Examples include the correct approved version, reconciliation to source records, inclusion of required tables or signatures, disposition of open comments, system access for the recipient, and documented approval when applicable.

Specify who will decide whether a deviation from the criteria is acceptable. If the deliverable will be used for clinical or regulatory decisions, incorporate the appropriate quality, medical, regulatory, data, or safety review rather than relying solely on project-manager acknowledgement.

4. Record dependencies, not just dates

Create one dependency entry for every item that can prevent another workstream from proceeding. A useful dependency states the upstream item, downstream activity, owner on each side, acceptance condition, target decision date, consequence of delay, and recovery option.

For example, a statistical programming output may depend on a finalized dataset and approved analysis rules. Rather than reporting both vendors as 'on track,' the project team should identify the exact evidence that unlocks the downstream work and who can resolve conflicts between the two schedules.

5. Separate an issue from a scope change

An operational issue is a problem with delivering an agreed obligation. A scope change alters the agreed obligation, assumptions, schedule, cost or approach. When an issue triggers a possible change, record both: the immediate containment or workaround and the proposed change with its impact on quality, timing, cost, resources, records and downstream deliverables.

Ask the vendor to document the options and assumptions. Keep approval of sponsor-controlled scope, budget, clinical, safety and regulatory decisions with the designated authorized sponsor owners. Update the applicable contract, statement of work, responsibility matrix, and plan when the approved change requires it.

6. Maintain a short decision log with visible closure

A useful decision record contains: a unique identifier; the question; options considered; essential evidence and version; authorized decision maker; date required; decision and rationale; affected workstreams; actions triggered; and location of the controlled record. A meeting note saying 'discussed offline' is not a closed decision.

Escalate early when a decision is missing, particularly when the downstream work has an irreversible commitment or a subject-safety implication. Set explicit triggers for escalation - for example, acceptance overdue beyond the agreed threshold, an unresolved data-integrity concern, or a change that could affect a trial's critical-to-quality factors. The threshold should be agreed in the project's governance plan, not invented retrospectively.

7. Make handoff completion a documented two-way event

A robust closeout includes the preparer's delivery confirmation and the recipient's acceptance or qualified rejection. Record the transfer location, accepted version, open exceptions, new owner, next action and planned follow-up. A partially accepted deliverable should be marked as such, with the exceptions assigned and tracked.

For personnel or vendor transitions, also transfer the live issue, risk, decision and action logs; contractual and budget assumptions; system and record-location knowledge; planned meetings; contact and escalation routes; and any outstanding oversight or quality actions. Resolve access changes through authorized procedures, not informal password sharing.

A one-page handoff record sponsors can adapt

Field	Minimum entry
Workstream and deliverable	Specific item, version, source system and intended use
Planned delivery / acceptance	Two distinct dates; downstream milestone date separately
Performer, reviewer, approver, recipient	Names or controlled roles, including sponsor decision authority
Acceptance criteria	Required content, evidence, quality checks and review outcome
Dependencies	Upstream inputs and downstream use; blocker thresholds
Open issues / changes	IDs, proposed action, risk and authorized decision route
Evidence and record location	Controlled file/link and version history
Result	Accepted, accepted with conditions, or rejected, with date
Next owner and escalation	Named role, deadline and alternate escalation route

 

A short scenario: when 'delivered' does not mean 'ready'

A central laboratory provides a revised transfer specification to the data-management vendor on schedule. The data-management team can open the document, but one analyte mapping remains unresolved. The project manager's dashboard shows delivery as complete. The downstream build, however, cannot be finalized without a medical or scientific decision on the mapping.

The better record separates file delivery from acceptance, assigns the mapping question to the appropriate scientific decision owner, logs the required decision date, documents any impact on the downstream build and records the final accepted version. It is a modest control, but it prevents a handoff from becoming a hidden dependency.

Regulatory context and practical boundary

ICH E6(R3) Good Clinical Practice emphasizes documented agreements covering transferred trial-related activities, sponsor oversight of service providers, and appropriate essential-record management. In the European Union, the EMA identifies the Principles and Annex 1 of E6(R3) as effective from 23 July 2025. As of November 2026, the consolidated version incorporating Annex 2 has a future EU effective date of 15 January 2027. The operational checklist above is an implementation aid, not a substitute for the applicable guideline, local laws or study agreements. Regulatory applicability and implementation dates should be checked for the jurisdiction and trial concerned.

Primary sources: European Medicines Agency, ICH E6 Good Clinical Practice guideline and current version information: https://www.ema.europa.eu/en/scientific-guidelines/ich-e6-good-clinical-practice

U.S. Food and Drug Administration, E6(R3) Good Clinical Practice (GCP), Final Guidance for Industry (September 2025): https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e6r3-good-clinical-practice-gcp

U.S. eCFR, 21 CFR 312.52, Transfer of obligations to a contract research organization: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-312/subpart-D/section-312.52

Further reading (affiliated, contextual): BioBoston CRO explains its approach to defined project-management scopes, sponsor decision ownership and workstream handoffs: https://biobostoncro.com/services/project-management/clinical-project-management/ . This is a company-affiliated reference, not independent validation of outcomes.

Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)